Bogunovic Lab

Menu

Join the Study

IRB APPROVED Study: IMMUNE SYSTEM IN DOWN SYNDROME

If you or your child has a diagnosis of Down syndrome, you may be eligible to be a part of our research study, which intends to better understand the immune system in individuals with Down syndrome. This study involves taking blood, saliva and/or skin samples from participants.

Participants are expected to be involved in the study for 15 years. Active involvement includes reading and signing a consent form that acknowledges the participant’s willingness to give a blood (3 – 4) tablespoons during each blood draw during 1 – 2 subsequent study visits.
Specifics on the risks and discomforts associated with blood draws are detailed in the consent form that is given to participants during the first visit.

Blood draws will take place at the Department of Infectious Diseases at the Icahn School of Medicine at Mount Sinai or other certified sites and institutions with whom we collaborate.

If you would like to become a part of our research study, please contact Dusan Bogunovic for more information.

This study has been approved under the Mount Sinai Program for the Protection of Human Subjects
(PPHS) under GCO#16-0275

_____________________________________________________

IRB APPROVED STUDY: Genetic predisposition to Neurolisteriosis

If you or someone you know has been diagnosed with neurolisteriosis and would like to become a part of our research study, please contact Dusan Bogunovic for more information.

Involved participants must have listeriosis and have tested positive for Listeria monocytogenes in their blood or cerebral-spinal fluid (spinal tap), or have a family history of the disease. Family members of patients diagnosed with neurolisteriosis are also encouraged to become involved in the study.

Participants are expected to be involved in the study for five (5) years. Involvement includes reading and signing a consent form that acknowledges the participant’s willingness to give a saliva sample. If needed, a staff doctor will draw blood (3 – 4 tablespoons during each blood draw) during 1 – 2 subsequent visits.

Specifics on the risks and discomforts associated with blood draws are detailed in the consent form that is given to participants during the first visit.

Blood draws will take place at the Department of Infectious Diseases at the Icahn School of Medicine at Mount Sinai.

This study has been approved under the Mount Sinai Program for the Protection of Human Studies (PPHS) under GCO#14-0812-00001-01-PD.